null
In Stock

Cardisure Flavoured Tablets 1.25mg (10 TABLETS)

Write a Review
$6.50
UPC:
9.32E+12
Current Stock:
$6.50

Description

Cardisure 1.25mg - 10 Tablets (Pimobendan)

Indicated for:
  • The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/ or tricuspid regurgitation).
  • The treatment of pre-clinical DCM in large breed dogs. When used in cases of preclinical DCM in large breed dogs, pimodendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes.
  • Doberman Pinscher dogs with preclinical DCM treated with pimobendan also demonstrated a significant reduction in Left Ventricular Internal Diameter in both systole and diastole (LVIDs/d) in response to therapy.
  • For the treatment of dogs with evidence of increased heart size secondary to asymptomatic (preclinical) myxomatous mitral valve disease to delay the onset of clinical symptoms of heart failure, to reduce heart size and to increase survival time.
PRESCRIPTION REQUIRED FOR THIS ITEM
  • This item is a prescription medication. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
  • All of Pet Care Pharmacy’s prescription medications are APVMA or TGA approved and are also identical to those supplied by your veterinarian.
Indication:
For the treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid regurgitation) or dilated cardiomyopathy.
Contraindication:
This product is contraindicated in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not recommended for functional or anatomical reasons (e.g. aortic stenosis).
Manufacturer:
Dechra
Trade Name:
Cardisure
Quantity:
10 Tablets
Refrigeration:
N/A
Active Ingredient:
Pimobendan 1.25mg

Product Reviews